Measurable residual disease-guided ibrutinib-venetoclax therapy achieved undetectable disease in bone marrow in 66.2% of patients with chronic lymphocytic leukemia (CLL) within 2 years compared with ...
Real-World Analysis of Disparities in Biomarker Testing and Use of Recommended Targeted Therapies in Metastatic Non–Small Cell Lung Cancer in the United States A total of 355 plasma samples were ...
Communicating effectively with other specialists on the care team is essential, says Aaron T. Gerds, MD, MS, Associate Professor of Medicine at Cleveland Clinic Lerner College of Medicine of Case ...
The number of people living with Parkinson's disease globally has doubled in the past 25 years. Yet the treatment and monitoring of the neurological disease seems many decades behind. Clinicians ...
Chronic cough in pulmonary fibrosis affects quality of life and correlates with mortality, yet objective measurement remains challenging. A wearable device combined with machine learning may offer a ...
SHANGHAI, China, 29 April 2025 -- In a comprehensive Genomic Press perspective article published today, researchers from Fudan University and Shanghai University of Traditional Chinese Medicine have ...
Despite major therapeutic advances, breast cancer remains prone to recurrence, particularly in patients with early-stage disease who appear disease-free after treatment. Follow-up care still relies ...
For patients, a new diagnosis of diabetes can be overwhelming. It means not only managing blood sugar but also preventing serious future health complications such as diabetic retinal disease, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results